Skip to content

Cost-effectiveness Evaluation of One Stage Versus Two Stage Exchange for Chronically Infected Total Hip and Total Knee Prostheses

Cost-effectiveness Evaluation of One Stage Versus Two Stage Exchange for Chronically Infected Total Hip and Total Knee Prostheses

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02651961
Acronym
IPRO
Enrollment
100
Registered
2016-01-11
Start date
2018-05-03
Completion date
2022-10-02
Last updated
2018-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronically Infected Total Hip of Knee Prosthesis

Keywords

Total hip prosthesis, Total knee prosthesis, Chronic infection, One stage exchange, Two stage exchange, Cost-effectiveness

Brief summary

Chronic infection after total joint arthroplasty generally requires implant exchange. Two stage exchange is considered as the gold standard procedure. However, some authors suggest that one stage exchange may be as effective. No consensus exists in the current literature. The purpose of the study was to evaluate the cost of both strategies in comparison to their success rate.

Detailed description

The primary criterion will be the cost-utility ratio (ICER) at 12 months follow-up. The secondary criteria will be: * quality of life; * pain; * persistence or recurrence of infection; * occurrence of complications ; * necessity for reoperation.

Interventions

PROCEDUREExchange of total hip or knee arthroplasty on same time

Removal of the index implants, extensive debridement, reimplantation of a new prosthesis

PROCEDUREExchange of total hip or knee arthroplasty in two time

Removal of the index implants in first time, extensive debridement, reimplantation of a new prosthesis in seconde time

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Chronically infected total hip or knee arthroplasty requiring implant exchange * Affiliation to a social security system * Signed informed consent * Effective contraception during all study

Exclusion criteria

* Repeat exchange after failure of a prior treatment for infection * Multiple implant infection * Infection due to mycobacteria or fungus * Pregnancy / Breast feeding * Patient under judicial protection * Impossibility to give informed consent for any reason * Participation to another study

Design outcomes

Primary

MeasureTime frame
Cost-utility ratio (ICER)12 months post-operative

Secondary

MeasureTime frameDescription
Pain : VAS score12 months post-operativePatient-reported pain score with visual analogic scale
Number of Persistence or recurrence of infection for all participants24 months post-operative
Occurrence of complications24 months post-operative
number of Necessity of reoperation for all patient12 months post-operativenecessity of reoperation will be assessed with clinical examination
Operating time of all surgical proceduresprocedureoperating time is from time of entrance in the operating room to time of the end of intervention (hh:mm)
Quality of life : EQ-5D questionnaire12 months post-operativePatient-reported generic (EQ-5D) outcomes questionnaire
Cost of complication treatment12 months post-operative
Cost of repeat surgery12 months post-operative
Quality of life : Oxford hip or knee questionnaires12 months post-operativePatient-reported specific (Oxford) outcomes questionnaire
cost of whole treatment12 months post-operative
Duration of whole treatment12 months post-operative

Countries

France

Contacts

Primary ContactHélène SOAVELO
helene.soavelo@chru-strasbourg.fr+33388116559

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026